rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Tariq Imam

SVP, Bus Dev, General Counsel

Company insider

Files Form 4 as: SVP, Bus Dev, General Counsel, Lisata Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
12
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
9 Jan 2026
Last trade
9 Jan 2026
Last filed
13 Jan 2026

Companies traded

Where they are an officer
LSTA Lisata TherapeuticsOfficer · Biotechnology · last 9 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code F$2,7601,401 at $1.97filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code F$1,655840 at $1.97filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,000 at $0.00filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code F$1,472747 at $1.97filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code F$1,011513 at $1.97filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,000 at $0.00filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code F$2,7601,401 at $1.97filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code F$1,655840 at $1.97filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code F$1,472747 at $1.97filing
9 Jan 2026filed 13 Jan 2026LSTA Lisata TherapeuticsBiotechnologySEC FORM 4 Code F$1,011513 at $1.97filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Steven M. KloskDirector · Director at Lisata Therapeutics, filing Form 4 there in the last year
Heidi HensonDirector · Director at Lisata Therapeutics, filing Form 4 there in the last year
Mohammad AzabDirector · Director at Lisata Therapeutics, filing Form 4 there in the last year
David J. MazzoPresident & CEO · President & CEO at Lisata Therapeutics, filing Form 4 there in the last year
Gregory B. BrownDirector · Director at Lisata Therapeutics, filing Form 4 there in the last year